Загрузка...
What do oncologists need to know about biosimilar products?
Many biologic products have improved the outcomes of cancer patients, but the costs can substantially burden healthcare systems. Biosimilar products can potentially reduce drug costs and increase patient access to beneficial treatments. Approval of a biosimilar product relies on the demonstration of...
Сохранить в:
| Опубликовано в: : | Chin J Cancer |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5062853/ https://ncbi.nlm.nih.gov/pubmed/27733189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-016-0151-x |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|